loadpatents
name:-0.048465013504028
name:-0.03652286529541
name:-0.00046205520629883
Gai; Yonghua Patent Filings

Gai; Yonghua

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gai; Yonghua.The latest application filed is for "substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists".

Company Profile
0.48.45
  • Gai; Yonghua - Irvine CA
  • Gai; Yonghua - North Grafton MA
  • Gai; Yonghua - Killingworth CT US
  • Gai; Yonghua - North Gratton MA
  • Gai; Yonghua - Norwood MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
Grant 10,131,655 - Sasmal , et al. November 20, 2
2018-11-20
Substituted Heterocyclic Acetamides As Kappa Opioid Receptor (kor) Agonists
App 20170001998 - SASMAL; Pradip Kumar ;   et al.
2017-01-05
Macrocyclic hepatitis C serine protease inhibitors
Grant 9,493,506 - Chen , et al. November 15, 2
2016-11-15
Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists
Grant 9,487,510 - Sasmal , et al. November 8, 2
2016-11-08
Macrocyclic hepatitis C serine protease inhibitors
Grant 9,309,279 - Ku , et al. April 12, 2
2016-04-12
Bismacrocyclic compounds as hepatitis C virus inhibitors
Grant 9,193,740 - Gai , et al. November 24, 2
2015-11-24
Quinoxalinyl derivatives
Grant 8,962,551 - Niu , et al. February 24, 2
2015-02-24
Quinoxaline-containing compounds as hepatitis C virus inhibitors
Grant 8,951,998 - Gai , et al. February 10, 2
2015-02-10
Substituted Heterocyclic Acetamides As Kappa Opioid Receptor (kor) Agonists
App 20150031685 - Sasmal; Pradip Kumar ;   et al.
2015-01-29
Fluorinated tripeptide HCV serine protease inhibitors
Grant 8,940,688 - Gai , et al. January 27, 2
2015-01-27
Macrocyclic compounds as hepatitis C virus inhibitors
Grant 8,936,781 - Gai , et al. January 20, 2
2015-01-20
Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20140287992 - Chen; Hui-Ju ;   et al.
2014-09-25
Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
Grant 8,809,264 - Niu , et al. August 19, 2
2014-08-19
Macrocyclic hepatitis C serine protease inhibitors
Grant 8,748,374 - Chen , et al. June 10, 2
2014-06-10
Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20140148573 - Ku; Yiyin ;   et al.
2014-05-29
.alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors
Grant 8,513,253 - Parker , et al. August 20, 2
2013-08-20
Difluorinated tripeptides as HCV serine protease inhibitors
Grant 8,501,682 - Gai , et al. August 6, 2
2013-08-06
Macrocyclic hepatitis C virus serine protease inhibitors
Grant 8,501,681 - Niu , et al. August 6, 2
2013-08-06
Quinoxaline-containing Compounds As Hepatitis C Virus Inhibitors
App 20130144036 - Gai; Yonghua ;   et al.
2013-06-06
Cyclic P3 tripeptide hepatitis C serine protease inhibitors
Grant 8,377,872 - Gai , et al. February 19, 2
2013-02-19
Fluorinated macrocyclic compounds as hepatitis C virus inhibitors
Grant 8,372,802 - Gai , et al. February 12, 2
2013-02-12
Oximyl HCV serine protease inhibitors
Grant 8,361,958 - Gai , et al. January 29, 2
2013-01-29
Quinoxaline-containing compounds as hepatitis C virus inhibitors
Grant 8,324,155 - Gai , et al. December 4, 2
2012-12-04
Triazole-containing macrocyclic HCV serine protease inhibitors
Grant 8,273,709 - Gai , et al. September 25, 2
2012-09-25
Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20120196792 - Ku; Yiyin ;   et al.
2012-08-02
Macrocyclic oximyl hepatitis C serine protease inhibitors
Grant 8,222,203 - Sun , et al. July 17, 2
2012-07-17
Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitors
Grant 8,211,891 - Gai , et al. July 3, 2
2012-07-03
Macrocyclic Hepatitis C Serine Protease Inhibitors
App 20120101031 - Chen; Hui-Ju ;   et al.
2012-04-26
Heteroaryl-containing tripeptide HCV serine protease inhibitors
Grant 8,101,567 - Gai , et al. January 24, 2
2012-01-24
Bismacrocyclic Compounds As Hepatitis C Virus Inhibitors
App 20110123496 - Gai; Yonghua ;   et al.
2011-05-26
Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors
App 20110105485 - Parker; Michael F. ;   et al.
2011-05-05
Quinoxalinyl dipeptide hepatitis C virus inhibitors
Grant 7,910,587 - Gai , et al. March 22, 2
2011-03-22
Macrocyclic Compounds As Hepatitis C Virus Inhibitors
App 20110033420 - Gai; Yonghua ;   et al.
2011-02-10
.alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors
Grant 7,786,122 - Parker , et al. August 31, 2
2010-08-31
Macrocyclic hepatitis C serine protease inhibitors
App 20100144608 - Ku; Yiyin ;   et al.
2010-06-10
Arylalkoxyl hepatitis C virus protease inhibitors
Grant 7,687,459 - Niu , et al. March 30, 2
2010-03-30
Quinoxaline-containing Compounds As Hepatitis C Virus Inhibitors
App 20100003214 - Gai; Yonghua ;   et al.
2010-01-07
Quinoxalinyl tripeptide hepatitis C virus inhibitors
Grant 7,635,683 - Gai , et al. December 22, 2
2009-12-22
Difluoromethyl-containing Macrocyclic Compounds As Hepatitis C Virus Inhibitors
App 20090274657 - Gai; Yonghua ;   et al.
2009-11-05
Acylaminoheteroaryl hepatitis C virus protease inhibitors
Grant 7,605,126 - Niu , et al. October 20, 2
2009-10-20
Fluorinated Macrocyclic Compounds As Hepatitis C Virus Inhibitors
App 20090238794 - Gai; Yonghua ;   et al.
2009-09-24
Heteroaryl-containing Tripeptide Hcv Serine Protease Inhibitors
App 20090202485 - GAI; YONGHUA ;   et al.
2009-08-13
Difluorinated Tripeptides As Hcv Serine Protease Inhibitors
App 20090202486 - GAI; Yonghua ;   et al.
2009-08-13
Fluorinated Tripeptide Hcv Serine Protease Inhibitors
App 20090197888 - GAI; YONGHUA ;   et al.
2009-08-06
Triazole-containing Macrocyclic Hcv Serine Protease Inhibitors
App 20090191151 - GAI; Yonghua ;   et al.
2009-07-30
Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxylamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182
Grant 7,563,877 - Xu , et al. July 21, 2
2009-07-21
Macrocyclic Oximyl Hepatitis C Serine Protease Inhibitors
App 20090180984 - Sun; Ying ;   et al.
2009-07-16
Quinoxalinyl Derivatives
App 20090180981 - Niu; Deqiang ;   et al.
2009-07-16
Oximyl Hcv Serine Protease Inhibitors
App 20090155210 - GAI; YONGHUA ;   et al.
2009-06-18
Hydroxyamic Analogs As Hepatitis C Virus Serine Protease Inhibitor
App 20090123423 - Gai; Yonghua ;   et al.
2009-05-14
Spirocyclic bicyclolides
Grant 7,517,859 - Gai , et al. April 14, 2
2009-04-14
Arylalkoxyl Hepatitis C Virus Protease Inhibitors
App 20090041721 - Niu; Deqiang ;   et al.
2009-02-12
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
App 20090005387 - Niu; Deqiang ;   et al.
2009-01-01
Oximyl Hydroxyamic Analogs As Hepatitis C Virus Protease Inhibitor
App 20080274082 - Gai; Yonghua ;   et al.
2008-11-06
Quinoxalinyl Dipeptide Hepatitis C Virus Inhibitors
App 20080267918 - Gai; Yonghua ;   et al.
2008-10-30
Cyclic P3 Tripeptide Hepatitis C Serine Protease Inhibitors
App 20080267916 - Gai; Yonghua ;   et al.
2008-10-30
Polymorphic Forms Of 6-11 Bicyclic Ketolide Derivatives
App 20080248105 - Tang; Datong ;   et al.
2008-10-09
Polymorphic forms of 6-11 bicyclic ketolide derivatives
Grant 7,384,921 - Tang , et al. June 10, 2
2008-06-10
Alpha-(n-sulfonamido)acetamide Derivatives As Beta-amyloid Inhibitors
App 20080085894 - Parker; Michael F. ;   et al.
2008-04-10
Acylaminoheteroaryl hepatitis C virus protease inhibitors
App 20080039470 - Niu; Deqiang ;   et al.
2008-02-14
Quinoxalinyl tripeptide hepatitis C virus inhibitors
App 20080032936 - Gai; Yonghua ;   et al.
2008-02-07
Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
App 20080008681 - Niu; Deqiang ;   et al.
2008-01-10
Quinoxalinyl Macrocyclic Hepatitis C Virus Serine Protease Inhibitors
App 20070299078 - Niu; Deqiang ;   et al.
2007-12-27
Tetracyclic bicyclolides
Grant 7,312,201 - Tang , et al. December 25, 2
2007-12-25
.alpha.-(N-sulfonamido)acetamide derivatives as .beta.-amyloid inhibitors
Grant 7,300,936 - Parker , et al. November 27, 2
2007-11-27
11,12-lactone bicyclolides
Grant 7,291,602 - Tang , et al. November 6, 2
2007-11-06
Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxylamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182
App 20070207972 - Xu; Guoyou ;   et al.
2007-09-06
3,6-Bicyclolides
Grant 7,229,972 - Or , et al. June 12, 2
2007-06-12
Spirocyclic bicyclolides
App 20060252713 - Gai; Yonghua ;   et al.
2006-11-09
11,12-Lactone bicyclolides
App 20060148731 - Tang; Datong ;   et al.
2006-07-06
3,6-bicyclolides
App 20060142214 - Or; Yat Sun ;   et al.
2006-06-29
Tetracyclic bicyclolides
App 20060142215 - Tang; Datong ;   et al.
2006-06-29
3,6-Bicyclolides
App 20060122128 - Or; Yat Sun ;   et al.
2006-06-08
Processes for the preparation of 6-11 bicyclic erythromycin derivatives
App 20060058248 - Xu; Guoyou ;   et al.
2006-03-16
Polymorphic forms of 6-11 bicyclic ketolide derivatives
App 20050203035 - Tang, Datong ;   et al.
2005-09-15
Processes for the preparation of 6-11 bicyclic erythromycin derivatives
App 20040171818 - Xu, Guoyou ;   et al.
2004-09-02
Alpha-(N-sulfonamido)acetamide derivatives as beta-amyloid inhibitors
App 20040127494 - Parker, Michael F. ;   et al.
2004-07-01
Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors
Grant 6,414,179 - Banville , et al. July 2, 2
2002-07-02
Alpha-substituted thio,-oxo trifluoromethylketones as phospholipase inhibitors
App 20020068722 - Banville, Jacques ;   et al.
2002-06-06
Alpha-and beta- substituted trifluoromethyl ketones as phospholipase inhibitors
App 20020065246 - Banville, Jacques ;   et al.
2002-05-30
Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
Grant 6,350,892 - Banville , et al. February 26, 2
2002-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed